Cargando…
Signaling Crosstalk of TGF-β/ALK5 and PAR2/PAR1: A Complex Regulatory Network Controlling Fibrosis and Cancer
Both signaling by transforming growth factor-β (TGF-β) and agonists of the G Protein-coupled receptors proteinase-activated receptor-1 (PAR1) and -2 (PAR2) have been linked to tissue fibrosis and cancer. Intriguingly, TGF-β and PAR signaling either converge on the regulation of certain matrix genes...
Autores principales: | Ungefroren, Hendrik, Gieseler, Frank, Kaufmann, Roland, Settmacher, Utz, Lehnert, Hendrik, Rauch, Bernhard H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6032192/ https://www.ncbi.nlm.nih.gov/pubmed/29795022 http://dx.doi.org/10.3390/ijms19061568 |
Ejemplares similares
-
The Role of PAR2 in TGF-β1-Induced ERK Activation and Cell Motility
por: Ungefroren, Hendrik, et al.
Publicado: (2017) -
Proteinase-Activated Receptor 2 May Drive Cancer Progression by Facilitating TGF-β Signaling
por: Ungefroren, Hendrik, et al.
Publicado: (2017) -
Proteinase-activated receptors (PARs) – focus on receptor-receptor-interactions and their physiological and pathophysiological impact
por: Gieseler, Frank, et al.
Publicado: (2013) -
Proteinase-Activated Receptor 2 Is a Novel Regulator of TGF-β Signaling in Pancreatic Cancer
por: Witte, David, et al.
Publicado: (2016) -
Proteinase-activated receptor 2 promotes TGF-β-dependent cell motility in pancreatic cancer cells by sustaining expression of the TGF-β type I receptor ALK5
por: Zeeh, Franziska, et al.
Publicado: (2016)